All In Biotech

Drug Trial Radar · NCT07101328

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

BAF_FRontier-1, A First-in-Human, Phase 1 Trial to Assess Safety, Tolerability, and Preliminary Efficacy of LY4152199, a B-cell Activation Factor Receptor (BAFF-R) T-Cell Engager Bispecific Antibody in Adult Participants With Previously Treated B-cell Malignancies

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 215 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

215

Planned (sponsor's estimate)

Start

May 28, 2026

Primary completion

Apr 2027

Study completion Sep 2029

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Aug 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies. Participants will have the option to continue taking LY4152199 until the study ends.

Conditions

  • Lymphoma, Non-Hodgkin
  • B-cell Lymphoma
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Follicular
  • Lymphoma, B-cell Marginal Zone
  • Waldenstrom Macroglobulinemia
  • Lymphoma, Mantle Cell

Interventions

  • LY4152199 - IVDrug

    Administered by IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1 - Number of Participants with Dose Limiting Toxicities (DLT) of LY4152199Time frame: Cycle 1 Day 1 through Cycle 2 Day 8 (35 days)

Locations

51 sites in 12 countries. Site status is shown where the registry gives one.

  • City of Hope

    Duarte, California · Recruiting

  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus

    Aurora, Colorado · Recruiting

  • Colorado Blood Cancer Institute

    Denver, Colorado · Recruiting

  • Yale University School of Medicine - Yale Cancer Center

    New Haven, Connecticut · Recruiting

  • The University of Chicago Medical Center (UCMC)

    Chicago, Illinois · Recruiting

  • University of Iowa

    Iowa City, Iowa · Recruiting

  • University of Kansas Cancer Center

    Kansas City, Kansas · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan · Recruiting

  • Mayo Clinic - Rochester

    Rochester, Minnesota · Recruiting

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey · Not yet recruiting

  • New York University (NYU) Clinical Cancer Center

    New York, New York · Recruiting

  • Weill Cornell Medicine

    New York, New York · Recruiting

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • University of Pennsylvania Abramson Cancer Center

    Philadelphia, Pennsylvania · Recruiting

  • SCRI Oncology Partners

    Nashville, Tennessee · Recruiting

  • University of Texas Southwestern

    Dallas, Texas · Recruiting

  • MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Intermountain Healthcare

    Salt Lake City, Utah · Not yet recruiting

  • Swedish Cancer Institute (SCI)

    Seattle, Washington · Recruiting

  • Froedtert Hospital and the Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • The Alfred Hospital

    Melbourne, VIC, Australia · Recruiting

  • Linear Clinical Research

    Nedlands, Australia · Recruiting

  • Lady Davis Institute for Medical Research Jewish General Hospital

    Montreal, Canada · Not yet recruiting

  • University Health Network (UHN) - Princess Margaret Cancer Centre

    Toronto, Canada · Not yet recruiting

  • BC Cancer - Vancouver

    Vancouver, Canada · Not yet recruiting

  • Aarhus University Hospital

    Aarhus, Denmark · Not yet recruiting

  • Center for Cancer and Organ Diseases - Rigshospitalet

    Copenhagen, Denmark · Not yet recruiting

  • CHU de Lille - Hopital Claude Huriez

    Lille, France · Not yet recruiting

  • AP-HP Hopital Saint-Louis

    Paris, France · Not yet recruiting

  • Charite Universitaetsmedizin Berlin

    Berlin, Germany · Not yet recruiting

  • LMU Klinikum Muenchen-Campus Grosshadern

    München, Germany · Not yet recruiting

  • Universitaetsklinikum Muenster

    Münster, Germany · Not yet recruiting

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola

    Bologna, Italy · Not yet recruiting

  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale

    Naples, Italy · Not yet recruiting

  • Istituto Clinico Humanitas

    Rozzano, Italy · Not yet recruiting

  • National Cancer Center Hospital East

    Chiba, Japan · Not yet recruiting

  • Okayama University Hospital

    Okayama, Japan · Recruiting

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.